• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, December 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

E-cigarettes popular among smokers with existing illnesses

Bioengineer by Bioengineer
February 21, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Ann Arbor, MI, Feb. 21, 2017 – In the U.S. more than 16 million people with smoking-related illnesses continue to use cigarettes. According to a new study in the American Journal of Preventive Medicine, current and former smokers who suffer from disease are more likely to have reported using an e-cigarette, meaning these patients may see e-cigarettes as safer or less harmful than combustible cigarettes and a way to reduce the risks posed by traditional smoking.

Use of electronic cigarettes has significantly increased in recent years. In 2010, only 2% of American adults had ever used an e-cigarette, but by 2014, that number had jumped to 12.6%. While most people see e-cigarettes as a safer alternative to traditional combustible smoking, many questions remain unanswered about their effects.

Using data from the 2014 and 2015 National Health Interview Survey (NHIS), investigators found that current smokers who also suffered from one or more medical conditions were more likely to have used an e-cigarette than "healthy" smokers (those without any comorbidities). The study included 36,697 adults in 2014 and 33,672 adults in 2015.

"This large sample provides the first national estimates of the prevalence of e-cigarette use among U.S. adults with medical comorbidities," explained lead investigator Gina R. Kruse, MD, MPH, Assistant Professor of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston. "Current smokers with medical comorbidities use e-cigarettes at higher rates than smokers without medical comorbidities. Very few never smokers with medical comorbidities have ever used e-cigarettes, except in the youngest age groups."

The data revealed that not only are smokers with comorbidities more likely to use e-cigarettes, but that e-cigarette use continues to rise, especially among present smokers (47.6% in 2014 vs. 53.5% in 2015). Current smokers with asthma, COPD, or cardiovascular disease reported e-cigarette use more often than other groups. Among former smokers, individuals with COPD reported more e-cigarette use compared to those without chronic disease; however, former smokers with cancer had lower odds of current e-cigarette use.

"Smokers with asthma, COPD, or cardiovascular disease probably use e-cigarettes for the same reasons as other adults: to quit cigarettes, reduce cigarette consumption, or reduce the harms from smoking," said Dr. Kruse. "Smokers with these chronic diseases may feel an urgent need to quit or reduce combustible cigarette use and may be willing to try new products. Conversely, among adults with cancer, the low prevalence of e-cigarette use may be because even a reduced harm product is seen as too late to help them."

While health care providers and researchers are still trying to fully understand possible health risks associated with e-cigarettes, there is a growing consensus that their use can possibly help people quit combustible cigarettes and curb tobacco-related risks. Switching to e-cigarettes might have greater positive impact for current smokers with health problems.

"E-cigarette use by current and former smokers with medical comorbidities is substantial, especially among individuals with chronic lung or cardiovascular disease. Clinicians should routinely ask these patients about e-cigarette use, assessing potential risks and benefits in terms of reducing or quitting combustible cigarette use. Clinicians should also actively consider all pathways to help their patients quit combustible cigarettes and recommend evidence-based treatments," commented Dr. Kruse.

###

Media Contact

Jillian B. Morgan
[email protected]
734-936-1590
@elseviernews

https://www.elsevier.com/

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Trehalose 6-Phosphate Lowers Echinocandin Resistance in Candidozyma auris

December 13, 2025

Hyperdynamic Circulation: A Key Obesity Indicator?

December 13, 2025

Rethinking Vigabatrin for Infantile Spasms: Risks and Insights

December 13, 2025

Impact of LED Light on Turmeric Pigment Stability

December 13, 2025
Please login to join discussion

POPULAR NEWS

  • Scientists Uncover Chameleon’s Telephone-Cord-Like Optic Nerves, A Feature Missed by Aristotle and Newton

    Scientists Uncover Chameleon’s Telephone-Cord-Like Optic Nerves, A Feature Missed by Aristotle and Newton

    121 shares
    Share 48 Tweet 30
  • Neurological Impacts of COVID and MIS-C in Children

    108 shares
    Share 43 Tweet 27
  • Nurses’ Views on Online Learning: Effects on Performance

    69 shares
    Share 28 Tweet 17
  • NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults

    70 shares
    Share 28 Tweet 18

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Trehalose 6-Phosphate Lowers Echinocandin Resistance in Candidozyma auris

Hyperdynamic Circulation: A Key Obesity Indicator?

Rethinking Vigabatrin for Infantile Spasms: Risks and Insights

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.